Canalevia-ca1, jaguar animal health's fda conditionally approved drug for chemotherapy-induced diarrhea (cid) in dogs, now available from chewy

Canalevia®-ca1 is the first and only treatment for cid in dogs to receive any type of approval from the fda san francisco, ca / accesswire / may 11, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") under its jaguar animal health tradename for the veterinary market, today announced that canalevia-ca1 (crofelemer delayed-release tablets), the company's u.s. food and drug administration (fda) conditionally approved prescription drug product for the treatment of chemotherapy-induced diarrhea (cid) in dogs, is now available on chewy , a trusted destination for pet parents and partners everywhere. "we are thrilled to have added chewy to the list of prominent pet retailers in the u.s. that offer canalevia-ca1.
JAGX Ratings Summary
JAGX Quant Ranking